BRIEF published on 02/06/2025 at 07:35, 1 year 3 months ago Vita 34 AG devient FamiCord AG pour renforcer sa présence internationale Croissance Internationale Relations Avec Les Investisseurs Changement De Marque FamiCord SA Banque De Cellules Souches
BRIEF published on 02/06/2025 at 07:35, 1 year 3 months ago Vita 34 AG Rebrands as FamiCord AG to Strengthen International Presence Rebranding Investor Relations International Growth FamiCord AG Stem Cell Banking
PRESS RELEASE published on 02/06/2025 at 07:30, 1 year 3 months ago Vita 34 AG strengthens its international brand presence by change of name to FamiCord AG Vita 34 AG rebrands to FamiCord AG to enhance international brand presence and facilitate further growth. Company maintains Vita 34 brand in DACH region Rebranding International Growth Vita 34 AG Cell Bank FamiCord AG
PRESS RELEASE published on 11/27/2024 at 10:11, 1 year 5 months ago Original-Research: Vita 34 AG (von Montega AG): Vita 34 AG Montega AG stuft Vita 34 AG positiv ein nach Veröffentlichung von Q3-Zahlen, inkl. Einmaleffekt. Prognose bestätigt, Umsatz- und EBITDA-Steigerungen Montega AG Vita 34 AG Prognose Q3-Zahlen Einmaleffekt
BRIEF published on 11/22/2024 at 07:05, 1 year 5 months ago Vita 34 annonce une croissance de son chiffre d'affaires et une augmentation de sa trésorerie au troisième trimestre 2024 Rentabilité Croissance Des Revenus Des Flux De Trésorerie Expansion Du Marché Banque Cellulaire
BRIEF published on 11/22/2024 at 07:05, 1 year 5 months ago Vita 34 Reports Revenue Growth and Cash Increase in Q3 2024 Revenue Growth Cash Flow Profitability Market Expansion Cell Banking
PRESS RELEASE published on 11/22/2024 at 07:00, 1 year 5 months ago Vita 34 continues to show increasing revenue, improved profitability and stronger cash generation in the third quarter of 2024 Vita 34 AG reports revenue growth of 6.3% to EUR 60.3 million, EBITDA up 77.5% in Q3 2024. Positive cash flow and strong performance despite market challenges EBITDA Revenue Growth Market Challenges Cash Flow Vita 34 AG
PRESS RELEASE published on 09/04/2024 at 16:16, 1 year 8 months ago Original-Research: Vita 34 AG (von Montega AG): Kaufen (zuvor: Halten) Montega AG stuft Vita 34 AG auf Kaufen mit erhöhtem Kursziel. Vita 34 verzeichnet leicht gesteigertes Wachstumstempo im 2. Quartal 2024 und bestätigt Guidance Montega AG Vita 34 AG Guidance Kaufen Wachstumstempo
BRIEF published on 08/30/2024 at 07:05, 1 year 8 months ago Vita 34 AG maintient sa croissance au premier semestre 2024 et augmente fortement son cash-flow opérationnel Vita 34 AG Croissance Des Revenus Augmentation De L'EBITDA Résultats Du 1er Semestre 2024 Flux De Trésorerie D'exploitation
BRIEF published on 08/30/2024 at 07:05, 1 year 8 months ago Vita 34 AG Sustains Growth in H1 2024, Strongly Boosts Operating Cash Flow Revenue Growth Operating Cash Flow Vita 34 AG EBITDA Increase H1 2024 Results
Published on 05/09/2026 at 01:30, 17 hours 43 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 19 hours 13 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 7 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 22 hours 35 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 23 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 23 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
